Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
1.590
-0.120 (-7.02%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Biofrontera Stock Forecast
BFRI's stock price has decreased by -85.8% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biofrontera stock has a target of 18, which predicts an increase of 1,032.08% from the current stock price of 1.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 31, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Biofrontera is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,032.08% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +1,032.08% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +8,705.03% | May 15, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +8,705.03% | Mar 9, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $220 → $140 | Strong Buy | Reiterates | $220 → $140 | +8,705.03% | Jan 31, 2023 |
Financial Forecast
Revenue This Year
41.51M
from 34.07M
Increased by 21.84%
Revenue Next Year
50.94M
from 41.51M
Increased by 22.70%
EPS This Year
-3.31
from -13.02
EPS Next Year
-0.56
from -3.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 42.9M | 54.3M | 68.6M | 101.0M | 122.3M |
| Avg | 41.5M | 50.9M | 66.6M | 98.1M | 118.8M |
| Low | 39.7M | 47.2M | 64.0M | 94.3M | 114.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.0% | 30.7% | 34.6% | 51.6% | 24.7% |
| Avg | 21.8% | 22.7% | 30.7% | 47.3% | 21.1% |
| Low | 16.5% | 13.8% | 25.6% | 41.5% | 16.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.60 | -0.20 | 0.86 |
| Avg | -3.31 | -0.56 | 0.84 |
| Low | -3.93 | -0.88 | 0.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.